Lactate to albumin ratio and bicarbonate conc. may predict mortality risk in patients with acute MI

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-11-27 14:30 GMT   |   Update On 2022-11-28 10:59 GMT
Advertisement

China: A recent study in BMC Cardiovascular Disorders has shown that lactate to albumin (L/A) ratio and bicarbonate concentration, and hemoglobin levels are good choices as predictors of 30-day mortality in acute myocardial infarction (AMI) patients.

The study showed that the lactate-to-albumin ratio correlated positively with the risk of 30-day all-cause mortality for AMI patients. An increase in mortality rate was seen with an increase in the L/A ratio. Further, bicarbonate concentrations < 22 mmol/L were associated inversely with 30-day mortality risk in patients with AMI. Lower concentrations of bicarbonate were tied to a higher 30-day mortality risk. The hemoglobin level, when less than 10 g/dl, was inversely associated with the mortality risk.

Advertisement

Previous studies have suggested that the L/A ratio is predictive of the prognosis of ICU patients with heart failure. Also, some studies have suggested that a low serum bicarbonate concentration is related inversely to the mortality risk of cardiogenic shock patients. However, there needs to be more clarity on the utility of the L/A ratio and bicarbonate for predicting the mortality risk of AMI patients. Therefore, Jia-Liang Zhu and colleagues from China conducted a retrospective study to explore this problem.

The study included patients with acute myocardial infarction; the data was obtained from an intensive care database. 30-day all-cause mortality after admission was recorded (primary endpoint). For endpoint events, a comparison was drawn between the predictive value of lactate, albumin, and L/A ratio. Also, the effects of different levels of L/A ratio and different bicarbonate concentrations were compared on 7-day and 30-day all-cause mortality.

The study revealed the following findings:

· The Area Under Curve (AUC) of lactate, L/A ratio, and albumin were 0.718, 0.736, and 0.620, respectively. (1) L/A ratio: The patients were categorized into three groups as per their L/A ratio: tertile T1 with L/A ratio ≤ 0.47, tertile T2 with L/A ratio ≤ 0.97, and tertile T3 with L/A ratio > 0.97. The T2 and T3 groups had more significant 30-day all-cause mortality risks compared to the T1 group.

· The restricted cubic spline (RCS) model suggested a nonlinear relationship between the L/A ratio and 30-day mortality.

· Bicarbonate concentration: The patients were also categorized into three groups as per their bicarbonate concentration: G1 with a concentration of 22–27 mmol/L, G2 with < 22 mmol/L, and G3 with > 27 mmol/L concentration. The G2 and G3 groups had more significant 30-day all-cause mortality risks compared to the G1 group.

· The RCS model revealed a nonlinear relationship between bicarbonate concentration and 30-day mortality.

· The RCS model revealed a nonlinear relationship between hemoglobin level and 30-day all-cause mortality.

"L/A ratio, bicarbonate concentration, and hemoglobin level are predictive for predicting 30-day mortality in acute myocardial infarction patients," the authors concluded.

Reference:

Zhu, JL., Liu, H., Wang, LL. et al. Association of lactate to albumin ratio and bicarbonate with short-term mortality risk in patients with acute myocardial infarction. BMC Cardiovasc Disord 22, 490 (2022). https://doi.org/10.1186/s12872-022-02902-4


Tags:    
Article Source : BMC Cardiovascular Disorders

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News